Literature DB >> 27769855

Acute Intermittent Porphyria in children: A case report and review of the literature.

Manisha Balwani1, Preeti Singh2, Anju Seth2, Ekta Malik Debnath3, Hetanshi Naik1, Dana Doheny1, Brenden Chen1, Makiko Yasuda1, Robert J Desnick4.   

Abstract

Acute Intermittent Porphyria (AIP), an autosomal dominant inborn error of heme metabolism, typically presents in adulthood, most often in women in the reproductive age group. There are limited reports on the clinical presentation in children, and in contrast to the adults, most of the reported pediatric cases are male. While acute abdominal pain is the most common presenting symptom in children, seizures are commonly seen and may precede the diagnosis of AIP. As an example, we report a 9year old developmentally normal pre-pubertal boy who presented with acute abdominal pain, vomiting and constipation followed by hyponatremia, seizures, weakness and neuropathy. After a diagnostic odyssey, his urine porphobilinogen was found to be significantly elevated and genetic testing showed a previously unreported consensus splice-site mutation IVS4-1G>A in the HMBS gene confirming the diagnosis of AIP. Here, we discuss the clinical presentation in this case, and 15 reported pediatric cases since the last review 30years ago and discuss the differential diagnosis and challenges in making the diagnosis in children. We review the childhood-onset cases reported in the Longitudinal Study of the Porphyrias Consortium. Of these, genetically and biochemically confirmed patients, 11 of 204 (5%) reported onset of attacks in childhood. Most of these patients (91%) reported recurrent attacks following the initial presentation. Thus, AIP should be considered in the differential diagnosis of children presenting with unexplained abdominal pain, seizures, weakness and neuropathy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute porphyria; Metabolic; Pediatric; Seizures

Mesh:

Substances:

Year:  2016        PMID: 27769855      PMCID: PMC5154763          DOI: 10.1016/j.ymgme.2016.10.005

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  23 in total

1.  Acute intermittent porphyria with transient cortical blindness.

Authors:  Javeed Iqbal Bhat; Umar Amin Qureeshi; Mushtaq Ahmad Bhat
Journal:  Indian Pediatr       Date:  2010-11       Impact factor: 1.411

2.  Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene.

Authors:  D H Llewellyn; S J Smyth; G H Elder; A C Hutchesson; J M Rattenbury; M F Smith
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 3.  ALAD porphyria.

Authors:  S Sassa
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

4.  Familial occurrence of myoclonic epilepsy syndrome and acute intermittent porphyria.

Authors:  Pavel Varsik; Darina Buranová; Branislav Kollár; Pavel Traubner; Peter Bozek; Miroslav Mikulecký
Journal:  Neuro Endocrinol Lett       Date:  2005-02       Impact factor: 0.765

5.  A retrospective study of a patient with homozygous form of acute intermittent porphyria.

Authors:  G J Beukeveld; B G Wolthers; Y Nordmann; J C Deybach; B Grandchamp; S K Wadman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Acute intermittent porphyria: a diagnostic challenge.

Authors:  Elizabeth Anyaegbu; Michael Goodman; Sun-Young Ahn; Mathula Thangarajh; Michael Wong; Marwan Shinawi
Journal:  J Child Neurol       Date:  2011-12-21       Impact factor: 1.987

7.  Acute intermittent porphyria, seizures, and antiepileptic drugs: a report on a 3-year-old Nigerian boy.

Authors:  R M Sykes
Journal:  Seizure       Date:  2001-01       Impact factor: 3.184

8.  [Acute intermittent porphyria associated with epilepsy in a child: diagnostic and therapeutic difficulties].

Authors:  Y Chaix; C Gencourt; E Grouteau; J P Carrière
Journal:  Arch Pediatr       Date:  1997-10       Impact factor: 1.180

9.  Acute intermittent porphyria in childhood: a population-based study.

Authors:  J Hultdin; A Schmauch; A Wikberg; G Dahlquist; C Andersson
Journal:  Acta Paediatr       Date:  2003-05       Impact factor: 2.299

10.  Molecular cloning and complete primary sequence of human erythrocyte porphobilinogen deaminase.

Authors:  N Raich; P H Romeo; A Dubart; D Beaupain; M Cohen-Solal; M Goossens
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

View more
  5 in total

Review 1.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

2.  Clinical Challenges of Acute Porphyria in the Young Adult.

Authors:  Shannon Burns; Allison Harmel; Sally Miller; Gabriela Figueiredo Pucci; Jonathan Greco; Michael Pulley; Michael Pizzi
Journal:  Neurohospitalist       Date:  2022-02-09

3.  Effect of Menstrual Cycle on Acute Intermittent Porphyria.

Authors:  V R Souza Júnior; V M V Lemos; I M L Feitosa; R Florencio; C W B Correia; L B Correia Fontes; M F Hazin Costa; M C B Correia
Journal:  Child Neurol Open       Date:  2017-10-18

Review 4.  Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Authors:  Helene J Bustad; Juha P Kallio; Marta Vorland; Valeria Fiorentino; Sverre Sandberg; Caroline Schmitt; Aasne K Aarsand; Aurora Martinez
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

5.  Acute Intermittent Porphyria in Prepubertal Child-diagnostic and Therapeutic Challenges in India: A Case Report and Literature Review.

Authors:  Ankita Goel Sharma; Kaveri Pandit; Shalu Gupta; Virendra Kumar
Journal:  Indian J Crit Care Med       Date:  2022-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.